Ozempic and Similar Drugs May Offer Health Benefits Beyond Weight Loss, Including Reduced Alcohol Cravings
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...
First pill to slow down Alzheimer’s considered for use on NHS
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
earth1d
Human brains hold dormant viruses that come to life if you hit your head
The study reveals a potential link between concussions and the activation of dormant viruses, which may lead to ...
Rolling Out5d
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
BioSpace4d
5 FDA Decisions to Watch in Q1
Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...
Neuroscience News3d
Head Trauma May Reactivate Dormant Viruses, Increasing Alzheimer’s Risk
New research suggests that concussions and repetitive head trauma may reactivate dormant viruses like HSV-1 in the brain, potentially triggering neurodegenerative diseases such as Alzheimer’s.